# OnCo record nct07462143 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07462143/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07462143", "NCT07462143" ;
  schema:name "A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer"@en ;
  schema:description "A phase 2/3 trial of RC148, CAPOX in colorectal cancer, run by RemeGen Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07462143/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07462143> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2026-05-12" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/rc148/>, <https://onco.cc/drugs/capox/> ;
  onco:companies <https://onco.cc/companies/remegen/> .
